E-LIB Suche - Ergebnisse für: Cuzzubbo, Stefania

1

Neuropathies optiques induites par les inhibiteurs de check..:

Cuzzubbo, Stefania ; Philippakis, Elise ; Louis, Evelaine...
Revue Neurologique. 180 (2024) - p. S56-S57 , 2024

Link: https://doi.org/10.1016/..

2

REVOLUMAB: A phase II trial of nivolumab in recurrent IDH m..:

Picca, Alberto ; Touat, Mehdi ; Belin, Lisa...
European Journal of Cancer. 202 (2024) - p. 114034 , 2024

Link: https://doi.org/10.1016/..

3

Prise en charge thérapeutique des neuropathies induites par..:

Cuzzubbo, Stefania ; D'oria, Francesco ; Baroudjian, Barouyr...
Revue Neurologique. 179 (2023) - p. S51-S52 , 2023

Link: https://doi.org/10.1016/..

4

Synthetic Melanin Acts as Efficient Peptide Carrier in Canc..:

Cuzzubbo, Stefania ; Roch, Benoit ; Darrasse-Jèze, Guillaume...
International Journal of Molecular Sciences. 23 (2022) 23 - p. 14975 , 2022

Link: https://doi.org/10.3390/..

5

Long-term Neurologic Safety in Patients With B-Cell Lymphom..:

Ursu, Renata ; Maillet, Didier ; Belin, Catherine...
Neurology. 99 (2022) 12 - p. 511-515 , 2022

Link: https://doi.org/10.1212/..

6

Troubles neurocognitifs et traitement par CAR-T cells:

Ursu, Renata ; Belin, Catherine ; Maillet, Didier...
Revue Neurologique. 178 (2022) - p. S142 , 2022

Link: https://doi.org/10.1016/..

7

Long-Term Neurological Safety in B-Cell Lymphoma Patients T..:

Ursu, Renata ; Maillet, Didier ; Belin, Catherine...
info:eu-repo/semantics/altIdentifier/doi/10.1212/wnl.0000000000201083. , 2022

Link: https://hal.univ-lille.f..

8

Synthetic Melanin Acts as Efficient Peptide Carrier in Canc..:

Stefania Cuzzubbo ; Benoit Roch ; Guillaume Darrasse-Jèze...
Molecular Oncology. , 2022

Link: https://doi.org/10.3390/..

9

Synthetic Melanin Acts as Efficient Peptide Carrier in Canc..:

Cuzzubbo, Stefania ; Roch, Benoit ; Darrasse-Jèze, Guillaume...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738778/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Synthetic Melanin Acts as Efficient Peptide Carrier in Canc..:

Cuzzubbo, Stefania ; Roch, Benoit ; Darrasse-Jèze, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms232314975. , 2022

Link: https://hal.science/hal-..

11

Synthetic Melanin Acts as Efficient Peptide Carrier in Canc..:

Cuzzubbo, Stefania ; Roch, Benoit ; Darrasse-Jèze, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms232314975. , 2022

Link: https://hal.science/hal-..

12

Synthetic Melanin Acts as Efficient Peptide Carrier in Canc..:

Cuzzubbo, Stefania ; Roch, Benoit ; Darrasse-Jèze, Guillaume...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms232314975. , 2022

Link: https://hal.science/hal-..

13

Synthetic Melanin Acts as Efficient Peptide Carrier in Canc..:

Stefania Cuzzubbo ; Benoit Roch ; Guillaume Darrasse-Jèze...
https://www.mdpi.com/1422-0067/23/23/14975. , 2022

Link: https://doi.org/10.3390/..

14

Long-Term Neurological Safety in B-Cell Lymphoma Patients T..:

Ursu, Renata ; Maillet, Didier ; Belin, Catherine...
info:eu-repo/semantics/altIdentifier/doi/10.1212/wnl.0000000000201083. , 2022

Link: https://hal.univ-lille.f..

15

Evaluation of mid-term (6-12 months) neurotoxicity in B-cel..:

Maillet, Didier ; Belin, Catherine ; Moroni, Christine...
Neuro-Oncology. 23 (2021) 9 - p. 1569-1575 , 2021

Link: https://doi.org/10.1093/..